Page 1 of 45
MLT-ASCP BOC PRACTICE EXAM 2026/2027 COMPLETE
(100) CURRENT TESTING QUESTIONS AND CORRECT
ANSWERS WITH DETAILED RATIONALES.
MLT-ASCP
Prepare for the MLT – ASCP BOC Exam with a focused study resource designed to
reinforce essential medical laboratory technician concepts. It supports review across
key laboratory areas including blood banking, chemistry, hematology, microbiology,
immunology, urinalysis, laboratory operations, and quality control. Use the material to
strengthen knowledge, improve application skills, and identify topics that may require
additional review before the certification examination. This resource is best suited for
Medical Laboratory Technician students, laboratory professionals, and MLT(ASCP)
certification candidates preparing for the ASCP Board of Certification exam.
MULTIPLE CHOICE.
SECTION 1: BLOOD BANKING (Immunohematology)
1. A patient's forward typing shows Anti-A: 4+, Anti-B: 0. Reverse typing
shows A1 cells: 0, B cells: 4+. What is the patient's ABO blood group?
• A) Group A
• B) Group B
• C) Group AB
• D) Group O
Answer: A) Group A
Rationale: Forward typing (cell typing) demonstrates the presence of A
antigen on the patient's red blood cells (Anti-A: 4+). Reverse typing (serum
typing) demonstrates the presence of anti-B antibodies in the patient's
serum (B cells: 4+). This pattern is consistent with Group A.
, Page 2 of 45
2. A patient types as group A, Rh positive. The antibody screen is negative.
Crossmatch with group A, Rh positive red blood cells is compatible. What
is the most likely interpretation?
• A) The patient has an alloantibody
• B) The patient has an autoantibody
• C) The patient has no unexpected antibodies
• D) The crossmatch is invalid
Answer: C) The patient has no unexpected antibodies
Rationale: A negative antibody screen indicates that no unexpected
(atypical) antibodies are present in the patient's serum. A compatible
crossmatch with group A, Rh positive cells confirms that the donor units
are compatible with the patient's serum.
3. According to AABB Standards, which of the following allogenic donors
may be accepted as a blood donor?
• A) A donor with a history of hepatitis B within the past 12 months
• B) A donor who received a blood transfusion within the past 3 months
• C) A donor who has traveled to a malaria-endemic area within the past 3
years
• D) A donor who has a history of taking antibiotics for a recent infection
but is now symptom-free
Answer: D) A donor who has a history of taking antibiotics for a recent
infection but is now symptom-free
Rationale: AABB Standards require that donors be in good health and free
from infections. A donor who has recovered from an infection and is no
longer on antibiotics may be accepted. Donors with hepatitis B (within 12
months), recent transfusions (within 3 months), or travel to malaria-
endemic areas (within 3 years) are typically deferred.
, Page 3 of 45
4. A patient's forward typing shows Anti-A: 4+, Anti-B: 4+. Reverse typing
shows A1 cells: 0, B cells: 0. What is the patient's ABO blood group?
• A) Group A
• B) Group B
• C) Group AB
• D) Group O
Answer: C) Group AB
Rationale: Forward typing shows both A and B antigens present on the red
blood cells. Reverse typing shows no anti-A or anti-B antibodies in the
serum. This pattern is consistent with Group AB.
5. In the ABO blood group system, which antibodies are naturally
occurring and typically of the IgM class?
• A) Anti-A and anti-B
• B) Anti-D
• C) Anti-K
• D) Anti-Fyª
Answer: A) Anti-A and anti-B
Rationale: Anti-A and anti-B antibodies are naturally occurring (found in
individuals who lack the corresponding antigen) and are typically IgM
class antibodies. They are capable of causing hemolytic transfusion
reactions if incompatible blood is transfused.
6. A patient has a positive direct antiglobulin test (DAT). What does this
indicate?
• A) The patient has unexpected antibodies in their serum
• B) The patient's red blood cells are coated with antibodies or
complement
, Page 4 of 45
• C) The patient has a positive antibody screen
• D) The patient has a weak D antigen
Answer: B) The patient's red blood cells are coated with antibodies or
complement
Rationale: A positive DAT indicates that antibodies or complement
components are bound to the patient's red blood cells in vivo. This can
occur in autoimmune hemolytic anemia, hemolytic transfusion reactions,
or hemolytic disease of the newborn.
7. What is the purpose of the antibody screen in pre-transfusion testing?
• A) To confirm the patient's ABO type
• B) To detect the presence of unexpected (atypical) antibodies in the
patient's serum
• C) To determine the patient's Rh type
• D) To crossmatch donor blood
Answer: B) To detect the presence of unexpected (atypical) antibodies in
the patient's serum
Rationale: The antibody screen (indirect antiglobulin test) is performed to
detect clinically significant unexpected antibodies in the patient's serum
that could cause hemolytic transfusion reactions. If the screen is
positive, further identification is performed.
8. Which Rh antigen is the most clinically significant and immunogenic?
• A) RhC
• B) Rhc
• C) RhE
• D) RhD
MLT-ASCP BOC PRACTICE EXAM 2026/2027 COMPLETE
(100) CURRENT TESTING QUESTIONS AND CORRECT
ANSWERS WITH DETAILED RATIONALES.
MLT-ASCP
Prepare for the MLT – ASCP BOC Exam with a focused study resource designed to
reinforce essential medical laboratory technician concepts. It supports review across
key laboratory areas including blood banking, chemistry, hematology, microbiology,
immunology, urinalysis, laboratory operations, and quality control. Use the material to
strengthen knowledge, improve application skills, and identify topics that may require
additional review before the certification examination. This resource is best suited for
Medical Laboratory Technician students, laboratory professionals, and MLT(ASCP)
certification candidates preparing for the ASCP Board of Certification exam.
MULTIPLE CHOICE.
SECTION 1: BLOOD BANKING (Immunohematology)
1. A patient's forward typing shows Anti-A: 4+, Anti-B: 0. Reverse typing
shows A1 cells: 0, B cells: 4+. What is the patient's ABO blood group?
• A) Group A
• B) Group B
• C) Group AB
• D) Group O
Answer: A) Group A
Rationale: Forward typing (cell typing) demonstrates the presence of A
antigen on the patient's red blood cells (Anti-A: 4+). Reverse typing (serum
typing) demonstrates the presence of anti-B antibodies in the patient's
serum (B cells: 4+). This pattern is consistent with Group A.
, Page 2 of 45
2. A patient types as group A, Rh positive. The antibody screen is negative.
Crossmatch with group A, Rh positive red blood cells is compatible. What
is the most likely interpretation?
• A) The patient has an alloantibody
• B) The patient has an autoantibody
• C) The patient has no unexpected antibodies
• D) The crossmatch is invalid
Answer: C) The patient has no unexpected antibodies
Rationale: A negative antibody screen indicates that no unexpected
(atypical) antibodies are present in the patient's serum. A compatible
crossmatch with group A, Rh positive cells confirms that the donor units
are compatible with the patient's serum.
3. According to AABB Standards, which of the following allogenic donors
may be accepted as a blood donor?
• A) A donor with a history of hepatitis B within the past 12 months
• B) A donor who received a blood transfusion within the past 3 months
• C) A donor who has traveled to a malaria-endemic area within the past 3
years
• D) A donor who has a history of taking antibiotics for a recent infection
but is now symptom-free
Answer: D) A donor who has a history of taking antibiotics for a recent
infection but is now symptom-free
Rationale: AABB Standards require that donors be in good health and free
from infections. A donor who has recovered from an infection and is no
longer on antibiotics may be accepted. Donors with hepatitis B (within 12
months), recent transfusions (within 3 months), or travel to malaria-
endemic areas (within 3 years) are typically deferred.
, Page 3 of 45
4. A patient's forward typing shows Anti-A: 4+, Anti-B: 4+. Reverse typing
shows A1 cells: 0, B cells: 0. What is the patient's ABO blood group?
• A) Group A
• B) Group B
• C) Group AB
• D) Group O
Answer: C) Group AB
Rationale: Forward typing shows both A and B antigens present on the red
blood cells. Reverse typing shows no anti-A or anti-B antibodies in the
serum. This pattern is consistent with Group AB.
5. In the ABO blood group system, which antibodies are naturally
occurring and typically of the IgM class?
• A) Anti-A and anti-B
• B) Anti-D
• C) Anti-K
• D) Anti-Fyª
Answer: A) Anti-A and anti-B
Rationale: Anti-A and anti-B antibodies are naturally occurring (found in
individuals who lack the corresponding antigen) and are typically IgM
class antibodies. They are capable of causing hemolytic transfusion
reactions if incompatible blood is transfused.
6. A patient has a positive direct antiglobulin test (DAT). What does this
indicate?
• A) The patient has unexpected antibodies in their serum
• B) The patient's red blood cells are coated with antibodies or
complement
, Page 4 of 45
• C) The patient has a positive antibody screen
• D) The patient has a weak D antigen
Answer: B) The patient's red blood cells are coated with antibodies or
complement
Rationale: A positive DAT indicates that antibodies or complement
components are bound to the patient's red blood cells in vivo. This can
occur in autoimmune hemolytic anemia, hemolytic transfusion reactions,
or hemolytic disease of the newborn.
7. What is the purpose of the antibody screen in pre-transfusion testing?
• A) To confirm the patient's ABO type
• B) To detect the presence of unexpected (atypical) antibodies in the
patient's serum
• C) To determine the patient's Rh type
• D) To crossmatch donor blood
Answer: B) To detect the presence of unexpected (atypical) antibodies in
the patient's serum
Rationale: The antibody screen (indirect antiglobulin test) is performed to
detect clinically significant unexpected antibodies in the patient's serum
that could cause hemolytic transfusion reactions. If the screen is
positive, further identification is performed.
8. Which Rh antigen is the most clinically significant and immunogenic?
• A) RhC
• B) Rhc
• C) RhE
• D) RhD
